Hareth Nahi

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Cancers

European journal of haematology

Leukemia

International journal of dermatology

Karolinska Institutet

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Oct 15 2001

Sweden

senior consultant/Researcher :: medicine

Education History

Karolinska Institutet Nov 01 1996

Sweden

PHD :: hematology

Publications

Anu Partanen, Anders Waage, Valdas Peceliunas, Schjesvold Fredrik, Pekka Anttila, Marjaana Säily, Katarina Uttervall, Mervi Putkonen, Kristina Carlson, Einar Haukas, Marja Sankelo, Damian Szatkowski, Markus Hansson, Anu Marttila, Ronald Svensson, Per Axelsson, Birgitta Lauri, Maija Mikkola, Conny Karlsson, Johanna Abelsson, Erik Ahlstrand, Anu Sikiö, Monika Klimkowska, Reda Matuzeviciene, Mona Hoysaeter Fenstad, Sorella Ilveskero, Tarja-Terttu Pelliniemi, Hareth Nahi, Raija Silvennoinen
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group. Cancers 16 (5) (2024)
Anu Partanen, Anders Waage, Valdas Peceliunas, Schjesvold Fredrik, Pekka Anttila, Marjaana Säily, Katarina Uttervall, Mervi Putkonen, Kristina Carlson, Einar Haukas, Marja Sankelo, Damian Szatkowski, Markus Hansson, Anu Marttila, Ronald Svensson, Per Axelsson, Birgitta Lauri, Maija Mikkola, Conny Karlsson, Johanna Abelsson, Erik Ahlstrand, Anu Sikiö, Monika Klimkowska, Reda Matuzeviciene, Mona Hoysaeter Fenstad, Sorella Ilveskero, Tarja-Terttu Pelliniemi, Hareth Nahi, Raija Silvennoinen
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group. Cancers 16 (5) (2024)
Thierry Facon, Gordon Cook, Saad Z Usmani, Cyrille Hulin, Shaji K Kumar, Torben Plesner, Cyrille Touzeau, Nizar J Bahlis, Supratik Basu, Hareth Nahi, Hartmut Goldschmidt, Hang Quach, Mohamad Mohty, Christopher P Venner, Katja C Weisel, Noopur Raje, Benjamin Hebraud, Karim Belhadj-Merzoug, Lotfi Benboubker, Olivier Decaux, Salomon Manier, Denis Caillot, Jon Ukropec, Huiling Pei, Rian Van Rampelbergh, Clarissa M Uhlar, Rachel Kobos, Sonja Zweegman
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA. Leukemia 36 (4) (2022)
Garbriel Afram, Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund, Muhammad Kashif, Gösta Gahrton, Evren Alici, Hareth Nahi
Conditioning with melphalan 200 mg/m 2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care. European journal of haematology 109 (6) (2022)
Hareth Nahi, Gabriel Afram, Hanna Brauner, Toomas Talme, Natalia Kuzmina
Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment. International journal of dermatology 60 (7) (2021)
Katharina Helene Susek, Charlotte Gran, Hans-Gustaf Ljunggren, Evren Alici, Hareth Nahi
Outcome of COVID-19 in multiple myeloma patients in relation to treatment. European journal of haematology 105 (6) (2020)
Charlotte Gran, Junfeng Wang, Hareth Nahi, Linda Koster, Gösta Gahrton, Herman Einsele, Riitta Niittyvoupio, Matthias Edinger, Dietrich Beelen, Fabio Ciceri, Martin Bornhäuser, Jürgen Finke, Liesbeth C de Wreede, Per Ljungman, Stephan Mielke, Johanna Tischer, Laurent Garderet, Stefan Schönland, Ibrahim Yakoub-Agha, Nicolaus Kröger
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT. British journal of haematology 189 (5) (2020)
Saad Z Usmani, Hareth Nahi, Maria-Victoria Mateos, Niels W C J van de Donk, Ajai Chari, Jonathan L Kaufman, Philippe Moreau, Albert Ortiol, Torben Plesner, Lofti Benboubker, Peter Hellemans, Tara Masterson, Pamela L Clemens, Man Luo, Kevin Liu, Jesús San F Miguel
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma. Blood 134 (8) (2019)
Michael Chrobok, Carin I M Dahlberg, Ece Canan Sayitoglu, Vladimir Beljanski, Hareth Nahi, Mari Gilljam, Birgitta Stellan, Tolga Sütlü, Adil Doganay Duru, Evren Alici
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells. Cancers 11 (1) (2019)
Hareth Nahi, Anna Genell, Göran Wålinder, Katarina Uttervall, Gunnar Juliusson, Forsberg Karin, Markus Hansson, Ronald Svensson, Olle Linder, Kristina Carlson, Bo Björkstrand, Sigurdur Y Kristinsson, Ulf Henrik Mellqvist, Cecilie Blimark, Ingemar Turesson
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register. European journal of haematology 99 (3) (2017)

Hareth Nahi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hareth Nahi